DTRM-555

· Zhejiang DTRM Biopharma

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for DTRM-555, covering 2025-01-08 to 2025-01-08. Get the full timeline:

Most recent: Clinical Trial Update: Study of a Triple Combination Therapy, DTRM-555, in Patients With R/R CLL or R/R Non-Hodgkin's Lymphomas [Phase 2]

See pricing